Cannflavin A, extracted from hemp aerial parts, was proven as a KMO inhibitor, with an IC50 = 29.4 μM, compared to the positive control Ro 61-8048 (IC50 = 5.1 μM), suggesting a possible therapeutical usage in neurodegenerative diseases [107]. This evidence concerns the gene KMO and neurodegenerative disease.